Compounding pharmacies need stricter FDA oversight
The current fungal meningitis outbreak has put a spotlight on compounding pharmacies, and regulators and stakeholders say Congress needs to clarify exactly who should regulate these entities.
The practice of compounding, which has been around for decades, was intended to give pharmacies the ability to produce a product under a doctor’s orders when a particular drug wasn’t available. …